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The  cytotoxic  activity  of -d-glucans  isolated  from  Agaricus  bisporus  and Lactarius  rufus  fruiting  bodies
was  evaluated  on  human  hepatocellular  carcinoma  cells  (HepG2).  NMR  and  methylation  analysis  suggest
that  these  -d-glucans  were composed  of  a linear  (1→6)-linked  and  a branched  (1→3),  (1→6)-linked
backbone,  respectively.  They  both  decreased  cell  viability  at concentrations  of  up  to  100  g mL−1, as
shown  by MTT  assay.  The  amount  of LDH  released  and  the  analysis  of  cell morphology  corroborated
these  values  and  also  showed  that  the -d-glucan  of L.  rufus  was  more  cytotoxic  to HepG2  cells  than
that  of  A.  bisporus.  The  treatment  of  HepG2  cells  with  L.  rufus  and  A.  bisporus  -d-glucans  at  a dose
−1
-d-Glucans
ytotoxicity
epG2 cells
of  200  g mL for 24  h  promoted  an  increase  of  cytochrome  c release  and  a decrease  of  ATP  content,
suggesting  that  these  polysaccharides  could  promote  cell  death  by  apoptosis.  Both  -d-glucans  were
tested  against  murine  primary  hepatocytes  at a dose  of  200  g mL−1. The  results  suggest that  the  L. rufus
-d-glucan  was  as  cytotoxic  for hepatocytes  as  for HepG2  cells,  whereas  the  A.  bisporus  -d-glucan,  under
the  same  conditions,  was  cytotoxic  only  for  HepG2  cells,  suggesting  cell  selectivity.  These  results  open
new  possibilities  for  use  of  mushroom  -d-glucans  in  cancer  therapy.. Introduction
Hepatocellular carcinoma (HCC) has become the third most
ommon cancer-related cause of death worldwide and the lead-
ng cause of death in patients with cirrhosis [1]. Many studies have
een done to decrease the incidence of these deaths [2–5]. Human
epatocellular carcinoma cells (HepG2) are considered an excellent
odel for investigating a compound’s cytotoxicity [6]. However,
any toxic compounds impair normal cellular functions, preven-
ing their use. Therefore, assessing the effects of these compounds
n normal cells, such as hepatocytes, can indicate selectivity.
The medicinal health beneﬁts and pharmacological poten-
ial of both edible and non-edible mushrooms have long
Abbreviations: Ab,  Agaricus bisporus linear (1→6)-linked -d-glucan; ASA,
cetylsalicylic acid; BSA, bovine serum albumin; DMSO, dimethylsulfoxide; HCC,
epatocellular carcinoma; HEPES, 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic
cid; LDH, lactate dehydrogenase; Lr,  Lactarius rufus branched (1→3)  (1→6)-linked
-d-glucan; MTT, 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide;
RIS, tris(hydroxymethyl)-aminomethane.
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been recognized, including their antitumor, immunostimulatory
and anti-inﬂammatory activities. Because their constituents are
believed to promote health and longevity, and also due to their
taste, texture, high ﬁber, and low fat contents [7–10], mushrooms
have long been consumed, especially in Asian countries. The bio-
logical importance of many mushrooms is primarily related to the
great structural diversity of their polysaccharides.
The mechanisms involved in the antitumor activity of polysac-
charides are not fully known. Most mushroom polysaccharides
seem to exert their antitumor activity via activation of multiple
pathways in the host immune response, or by acting as biologi-
cal response modiﬁers [11,12]. Promising antitumor activity has
been attributed to several polysaccharides [12,13], and many of
them are also used as adjuvants in chemotherapy treatment for
different types of tumors. Among the best known are the com-
mercial polysaccharides lentinan, derived from Lentinus edodes;
PSK (krestin), extracted from Coriolus versicolor; and schizophyllan,
produced by the fungus Schizophyllum commune [14].
Polysaccharides with antitumor action possess a speciﬁc chem-
Open access under the Elsevier OA license.ical composition and molecular conﬁguration and may  be in the
form of homo- or heteropolymers. Among the molecules with anti-
tumor activity, most belong to the -d-glucan group [11,15,16].
Their structure consists mainly of a -(1→3)-linked main-chain
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ith branches at O-6, which are believed to be necessary for their
ntitumor action [13]. Glucans with a high molecular weight seem
o be more effective than those with a low molecular weight. The
ain polysaccharides found in mushrooms belong to the class of
-d-glucans [17–19], although heterogalactans [20–24] and xylo-
anans [25] can also be found.
Considering that some polysaccharides extracted from mush-
ooms have antitumor activity, the effect of two different
-d-glucans on HepG2 cells was evaluated with the intent of show-
ng potential cytotoxic effects and also identifying the pathways
nvolved. To evaluate the inﬂuence of polysaccharide structures, a
inear and a branched -d-glucan, extracted from Agaricus bisporus
nd Lactarius rufus fruiting bodies, respectively, were tested.
A. bisporus, commonly known as the button mushroom, is the
ost widely consumed mushroom and contains many compounds
ith medicinal properties, including polysaccharides [22,26–28].
n contrast, L. rufus is generally not recommended for consump-
ion [29,30] because, like other mushrooms belonging to the genus
actarius, it releases a milky juice, lactate, when the fruiting bod-
es are injured [31]. However, in some regions, this mushroom is
sed as a condiment after special treatment [32]. In the majority of
actarius species, different types of sesquiterpenes play an impor-
ant biological role, mainly constituting a chemical defense system
gainst predators [31,33], meanwhile the biological potential of
heir polysaccharides is not well known [22].
Consequently, comparisons of the effects of isolated -d-
lucans from A. bisporus and L. rufus on the viability and morphology
f tumor cells and primary hepatocytes were carried out, and a
elective antitumor activity was demonstrated.
. Materials and methods
.1. Reagents
d-Mannitol, HEPES, EDTA, BSA, digitonin, penicillin, strepto-
ycin, Tris, bicarbonate, MTT, collagenase type IV and 1A, glucagon,
nsulin, epidermal growth factor and trypsin were obtained from
igma–Aldrich. High glucose DMEM,  fetal bovine serum and hep-
tozyme were purchased from Gibco, and DMSO, KCl, sodium
hosphate and potassium phosphate, together with other reagents
f high purity, were purchased from Merck.
.2. Polysaccharides
.2.1. Biological material
Dried fruiting bodies of A. bisporus were obtained from Makoto
amashita Company (Miriam Harumi Yamashita), São José dos Pin-
ais, State of Paraná, Brazil. L. rufus fruiting bodies were collected
n the middle of May  2005 from the soil of a Pinus sp. reforestation
roject located in Mafra, State of Santa Catarina, Brazil, at latitude:
6◦13′S; longitude: 49◦50′W and altitude of 826 m above sea level.
hese samples were cleaned, vacuum dried, and then ground to a
owder.
.2.2. Extraction and puriﬁcation of ˇ-d-glucans
Dried, Wiley-milled powder fruiting bodies from A. bisporus (Ab;
00 g) and L. rufus (Lr; 42.2 g) were each submitted to successive
old and hot aqueous extraction, both for 6 h (6×;  approximately
000 mL  each). The cold water extractions were performed to
emove cold water-soluble compounds, which were not used in
he present study.
The extracted polysaccharides were recovered from aqueous
xtracts by addition of excess ethanol (3:1; v/v), followed by cen-
rifugation at 8000 rpm at 5 ◦C for 20 min. The sediments were
ialyzed against tap water for 24 h (12–14 kDa cut-off), concen-
rated under reduced pressure, and freeze-dried. The A. bisporuslogical Macromolecules 58 (2013) 95– 103
and L. rufus extracts were named HW-Ab and HW-Lr, respectively.
Both crude extracts were fractionated by a freeze-thawing process
[34], where Hw-Ab and HW-Lr fractions were dissolved in water,
and the solutions were subjected to freezing and slow thawing until
complete separation of cold-water soluble (SHW) and insoluble
polysaccharides (IHW).
An A. bisporus insoluble fraction (IHW-Ab), obtained after
centrifugation (8000 rpm at 5 ◦C for 20 min), was  treated with
dimetylsulfoxide (50 mL)  for 2 h at 60 ◦C, dialyzed against tap
water for 24 h, and then resubmitted to the freeze-thawing pro-
cess, resulting in a soluble -d-glucan fraction, named Ab [35].
Meanwhile, to obtain L. rufus -d-glucan, its cold water soluble
fraction was treated with Fehling solution [36]. The Fehling-soluble
fraction (FSHW) was  isolated with an insoluble Cu2+ complex, cen-
trifuged under the same conditions as described above, neutralized
with HOAc, dialyzed against tap water, deionized with mixed-ion
exchange resins and then freeze dried. This process resulted in the
isolation of a -d-glucan, named Lr [37].
The isolated -d-glucans were dissolved in phosphate-buffered
solution (PBS) at 1 mg  mL−1 and sterilized by heat at 100 ◦C for
90 min  for assays with cells.
2.3. Monosaccharide composition of polysaccharide fractions
Each polysaccharide fraction (1 mg)  was  hydrolyzed with 2 M
TFA at 100 ◦C for 8 h, followed by evaporation. The resulting residue
was reduced with NaBH4 (1 mg)  and acetylated with Ac2O–pyridine
(1:1, v/v; 200 L) at 100 ◦C for 30 min  following the method of
Sassaki et al. [38]. The resulting alditol acetates were analyzed
by gas chromatography–mass spectrometry (GC–MS), using a Var-
ian model 3300 gas chromatograph linked to a Finnigan Ion-Trap,
Model 810-R12 mass spectrometer. A DB-225 capillary column
(30 m × 0.25 mm i.d.) held from 50 ◦C during injection and then
programmed to 220 ◦C (constant temperature) at 40 ◦C min−1 was
used for qualitative and quantitative analysis of alditol acetates.
The alditol acetates were identiﬁed by their typical retention times
and electron impact proﬁles.
2.4. Methylation analysis of ˇ-d-glucans
Per-O-methylation of isolated -d-glucans (Ab and Lr;  10 mg)
was carried out using NaOH–Me2SO–MeI as described by Ruthes
et al. [39]. This process, after isolation of the products by neutral-
ization (HOAc), dialysis, and evaporation, was  repeated, and the
methylation was then complete. The per-O-methylated derivatives
were hydrolyzed with 45% formic acid (HCO2H, 1 mL)  for 15 h at
100 ◦C [18], followed by NaBD4 reduction and acetylation as above
(Section 2.3), to give a mixture of partially O-methylated alditol
acetates, which was  analyzed by GC–MS using a Varian model 4000
gas chromatograph, equipped with CP-Sil-43CB fused silica capil-
lary columns. The injector temperature was  maintained at 210 ◦C,
with the oven starting at 50 ◦C (hold 2 min) to 90 ◦C (20 ◦C min−1,
then held for 1 min), 180 ◦C (5 ◦C min−1, then held for 2 min) and
to 210 ◦C (3 ◦C min−1, then held for 5 min). Helium was used as the
carrier gas at a ﬂow rate of 1.0 mL  min−1. Partially O-methylated
alditol acetates were identiﬁed from m/z by comparing their pos-
itive ions with standards, the results being expressed as a relative
percentage of each component [40].
2.5. Nuclear magnetic resonance (NMR) spectroscopy
Monodimensional (13C and DEPT) NMR  spectra were pre-
pared using a 400 MHz  Bruker model DRX Avance spectrometer
incorporating Fourier transform. Analyses were performed at
70 ◦C on samples dissolved in D2O or Me2SO-d6. Chemical shifts
of water-soluble samples are expressed in ı (ppm) relative to
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cetone at ı 30.20 (13C), and at ı 39.70 (13C) for those dissolved
n Me2SO-d6.
.6. Animals
Male Wistar rats (180–200 g) were obtained from the Central
nimal House of the Federal University of Parana (PR, Brazil). The
nimals were housed at 22 ± 1 ◦C under a 12 h light–12 h dark
ycle and had free access to standard laboratory food (Purina®)
nd tap water. The experiments were conducted following the rec-
mmendation of Brazilian Law 6638, 05/11/1979 for the scientiﬁc
anagement of animals, and the procedures were approved by the
nstitutional Animal Ethics Committee (number 548).
.7. HepG2 cell culture and treatment
HepG2 cells were acquired from the Rio de Janeiro Cell
anc, Brazil. They were cultured in Dulbecco’s Modiﬁed Eagle’s
edium (DMEM)-high glucose (Gibco) supplemented with 10%
etal bovine serum, 100 U mL−1 penicillin G, 100 g mL−1 strep-
omycin, 20 mmol  L−1 HEPES, adjusted to pH 7.4 with 1 mol  L−1
odium bicarbonate. HepG2 cells were grown in poly-l-lysine-
oated ﬂasks in a humidiﬁed incubator in the presence of 5% CO2 at
7 ◦C. Sub-culturing was performed at approximately 48 h inter-
als, and cell growth was monitored with an Olympus inverted
icroscope.
Polysaccharide treatments occurred 24 h after the cells were
eeded on the plates. The -d-glucans were dissolved in culture
edium at 50, 100, 200 or 400 g mL−1 and incubated for 12, 24 or
8 h.
.8. Isolation of primary murine hepatocyte, culture and
reatment
Hepatocytes were obtained under monovascular liver per-
usion of Wistar rats, as described previously by Seglen [41], with
odiﬁcations. Male rats were weighed and anesthetized intraperi-
oneally with a mixture of cetamine (60 mg  kg−1) and xylazine
7.5 mg  kg−1). Following laparotomy, 100 L of sodium heparin
5000 U mL−1) were injected into the abdominal cava vein. The
ortal and thoracic cava veins were cannulated, and the liver was
erfused with Krebs solution (NaCl 2.399 mol  L−1; KCl 96 mmol  L−1;
H2PO4 24 mmol  L−1; MgSO4 24 mmol  L−1; NaHCO3 480 mmol  L−1
nd HEPES buffer 1 mol  L−1, pH 7.4) containing CaCl2 1.3 mol  L−1,
ollagenase (type IA and IV) and carbogen (O2 95%; CO2 5%).
he liver was excised, and the cells were released by mechanical
ction, ﬁltered through 50 m nylon membranes and centrifuged at
00 rpm for 5 min  at 4 ◦C. Subsequently, the cells were centrifuged
our times with Krebs solution supplied with 20% bovine serum
lbumin (BSA), also treated with carbogen. The cells were sus-
ended in DMEM high glucose medium supplied with bovine fetal
erum (10%), insulin (100 nmol L−1), glucagon (10 nmol L−1), epi-
ermal growth factor (10 ng mL−1), dexamethasone (50 nmol L−1),
enicillin (100 U mL−1) and streptomycin (100 ng mL−1). The via-
ility was determined using the Trypan blue (0.4%, w/v) exclusion
ethod, previously described by Philips [42]. Only cell suspensions
ith viabilities higher than 80% were plated (1 × 106 cells/plate on
 60 mm plate) and cultured for further experiments. Four hours
fter plating, the medium was replaced by Hepatozyme®, with or
ithout polysaccharide, and incubated for 18 h prior to assays..9. Viability assays
HepG2 cells (1 × 104 cells/well) were seeded in 96-well plates
nd cultured in a humidiﬁed incubator overnight for adhesion.logical Macromolecules 58 (2013) 95– 103 97
The medium was replaced by medium with or without polysac-
charides at 50–400 g mL−1 for 24, 48 or 72 h. After incubation,
the medium was  discarded, and a tetrazolium dye (MTT) solution
(0.75 mg  mL−1) was  added. For hepatocyte assays, cells were only
treated with the polysaccharides for 24 h. The plates were allowed
to stand at 37 ◦C for 3 h. The MTT-formazan crystals that formed
were dissolved in DMSO, and absorbance was  measured at 540 nm
using a microplate reader [3,43]. Cell viability is expressed as per-
cent of control.
Under the same conditions, the viability of HepG2 cells and
hepatocytes was also determined by releasing LDH  into the culture
medium, using an LDH assay kit (Labtest) according to the manufac-
turer’s recommended protocol. After the polysaccharide treatment,
the supernatant was  collected and centrifuged at 1200 rpm for
10 min, and LDH activity was measured. The results are expressed
as a percentage of the control.
2.10. Morphological analysis
The morphological changes in hepatocytes and HepG2 cells
were examined with an Axiovert 40CSFL inverted microscope with
20× magniﬁcation.
2.11. Measurement of ATP content
The intracellular ATP content was  determined using an ATP Bio-
luminescent assay kit from Sigma-Aldrich (FLAA) according to the
manufacturer’s protocol. The ATP measurement is based on the oxi-
dation of d-luciferin catalyzed by ﬁreﬂy luciferase enzyme, which
consumes ATP with concomitant light emission. Bioluminescence
was measured with a TECAN Inﬁnite reader, and the ATP concentra-
tion (nmol L−1) was calculated using a standard curve (ATP ranging
from 0 to 100 mol  L−1). The results are expressed as a percentage
of the control.
2.12. Measurement of cytochrome c release
Cytochrome c release was monitored spectrophotometrically
by absorbance variation at 414 nm according to Appaix et al.
[44]. HepG2 cells (1 × 106/plate) were seeded in a 60 mm  plate
and incubated with polysaccharides for 24 h. After incubation,
cells were harvested using trypsin solution and centrifuged at
1200 rpm for 10 min  at 4 ◦C. The pellet was  suspended in a
medium containing sucrose (50 mmol  L−1), Tris–HCl (10 mmol L−1)
and EGTA (3 mmol  L−1). Cells were permeabilized with digitonin
at 10 mol  mL−1 for 30 min  at 4 ◦C. The cell suspension was  cen-
trifuged at 10,000 × g for 10 min. The supernatant was ﬁltered
through a 22 m individual ﬁlter, and optical density was  mea-
sured at 414 nm,  considering ε = 100 mM−1 cm−1. The results are
expressed as a percentage of the control.
2.13. Protein determination
The protein concentration in samples was  determined using the
Bradford method [45].The data were statistically analyzed using variance analysis
and Tukey’s test for average comparison using GraphPad Prism
software. Mean values ± S.D. were used; values were considered
signiﬁcant at P < 0.05.
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. Results and discussion
.1. ˇ-d-Glucans structural characterization
The -d-glucans obtained from A. bisporus (Ab; 8.0 g, 8%)
nd L. rufus (Lr;  0.6 g, 1.4%) were shown to be homogeneous
n HPSEC, with molecular weights of 2.9 × 104 g mol−1 and
1.3 × 104 g mol−1, respectively. Each puriﬁed Ab and Lr frac-
ion contained only glucose as their monosaccharide component
GC–MS). GC–MS analysis of their partially O-methylated alditol
cetates suggested that the Ab fraction was composed of a linear
1→6)-linked -d-glucan due to the presence of only 2,3,4-Me3-
lc (100%). In contrast, the Lr fraction was composed of a branched
1→3), (1→6)-linked -d-glucan due to the presence of 2,3,4,6-
e4-Glc (32.0%), 2,4,6-Me3-Glc (36.4%), and 2,4-Me2-Glc (31.6%),
-methyl alditol acetates.
13C NMR  spectroscopy of fraction Ab showed a (1→6)-linked
-glucan by the presence of only six signals (Fig. 1A). All carbon
requencies were assigned according to literature data [46], and
he -conﬁguration was conﬁrmed by the high frequency of its
nomeric carbon at ı 103.3 [47]. The other carbon frequencies were
ssigned as C-2 (ı 73.5), C-3 (ı 76.7), C-4 (ı 70.2), C-5 (ı 75.5), and
-6 (ı 68.6) [35], as shown in Fig. 1A. The O-substituted −CH2 (C-6)
ignal was conﬁrmed by its inversion in a DEPT-13C NMR  spectrum
Fig. 1A′). On the other hand, NMR  spectroscopy of fraction Lr con-
rmed the presence of a branched (1→3),  (1→6)-linked -d-glucan
Fig. 1B). Its 13C NMR  spectrum showed three distinct signals in the
nomeric region at ı 103.0, 102.9 and 102.6, corresponding to the′ and B′ , respectively). -d-Glucans were prepared in Me2SO-d6 (A) and D2O (B) at
nonreducing end-, 3-O- and 3,6-di-O-substituted residues, respec-
tively. The -conﬁguration was  also conﬁrmed by high-frequency
C-1 signals (ı 103.1, 102.9 and 102.6) (Fig. 1B) [47].
The glycosidic linkages of fraction Lr were shown by the pres-
ence of 3-O-substituted signals at ı 85.5, 85.1, 84.9 and 84.7
(Fig. 1B), while the O-6 substitution was  conﬁrmed from the respec-
tive inverted peak in its DEPT spectrum (Fig. 1B). After a controlled
Smith degradation, the backbone structure of Lr glucan was shown
by formation of its linear main-chain of a (1→3)-linked -d-glucan,
due to the presence of typical 13C signals at ı 102.9 (C-1); 86.2 (C-
3); 76.5 (C-5); 72.8 (C-2); 68.5 (C-4), and 61.0 (C-6) [37,48]. In the
degraded fraction, low intensity signals from O-6 substitution were
still present, indicating that this glucan is mostly substituted at O-6
by single units of -d-glucopyranose with a minor proportion by
side chains of 3-O-substituted -d-Glcp groups [37].
3.2. Cellular viability
Cell viability was  evaluated by two  methods, MTT  and LDH
release assays. The results of the MTT  assays for HepG2 cells are
shown in Fig. 2A–C. The -d-glucan from L. rufus (Lr)  was cytotoxic
after 24 h of incubation at concentrations above 100 g mL−1,
decreasing viability up to ∼30% at the highest concentration
(400 g mL−1; Fig. 2A). Meanwhile, A. bisporus -d-glucan (Ab)
was more toxic than Lr,  promoting cell death at 50 g mL−1.
At the highest concentration (400 g mL−1), the polysaccharide
decreased cell viability by ∼70%. These effects on HepG2 cell viabil-
ity were more pronounced when the incubation with the polymers
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Fig. 2. Cell viability assay by MTT. Conditions for this assay are described in Section 2. In vitro cytotoxicity of Lr and Ab against HepG2 cells after incubation of 24 h (A), 48 h
(B)  and 72 h (C) and primary hepatocyte after 18 h incubation (D). The results represent the mean ± S.D. of four different experiments. Asterisks indicate signiﬁcant difference
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as carried out for 48 h and 72 h (Fig. 2B and C). However, at these
imes, the toxicity of Lr and Ab at the highest concentration tested
400 g mL−1) were equivalent, promoting almost complete cell
eath. These results demonstrate that both -d-glucans tested
ere toxic to HepG2 cells and that this cytotoxicity is dependent
n concentration and time of incubation. Considering the high
ytotoxicity of the polymers after the longest periods of treatment
48 and 72 h), for the next experiments, the concentration of
00 g mL−1 was used with an incubation time of 24 h.
The viability of hepatocytes evaluated by the MTT  method is
hown in Fig. 2D. In these assays, the time of treatment was
imited to 24 h, and the concentration of polysaccharides was
imited to 200 g mL−1. In Fig. 2D, only Lr was cytotoxic for pri-
ary hepatocytes, decreasing cell viability by ∼75%. These results
orroborate the effects of polysaccharides observed in HepG2 cells,
here Lr was more cytotoxic on these cells under the same condi-
ions (200 g mL−1 and 24 h of incubation). Interestingly, while Ab
200 g mL−1 and 24 h of incubation) was able to decrease HepG2
ell viability by ∼10% (Fig. 2A), it did not affect hepatocyte viability
Fig. 2D).
The LDH assay (Fig. 3) also showed that Lr and Ab were differen-
ially cytotoxic to HepG2 cells (Fig. 2). Treatment with -d-glucans
romoted an increase of LDH release that reﬂects a decrease in cell
iability. In this assay, after 24 h incubation (Fig. 3A), Lr promoted
n increase of LDH release of ∼29% at the lowest concentration
50 g mL−1) and reached a release of ∼56% at 400 g mL−1, in com-
arison with the control. After 48 h (Fig. 3B) and 72 h (Fig. 3C), the
alues of LDH release are similar to those of the 24 h incubation
Fig. 3A), suggesting that this effect is independent of the incubationtime. A similar proﬁle was  seen for Ab treatment. At 24 h, Ab pro-
moted a ∼30% increase of LDH release at 50 g mL−1, reaching ∼35%
at 200 g mL−1 (Fig. 3A). These values remained unchanged after
48 h incubation (Fig. 3B) with Ab; however, a decrease after 72 h was
observed, with LDH release near to 25% at 100 and 200 g mL−1. At
the highest concentration (400 g mL−1) Ab increased LDH release
by ∼17% and ∼24% after 24 h and 48 h of incubation, respectively.
Interestingly, after 72 h incubation (Fig. 3C), 50 and 400 g mL−1
Ab was not signiﬁcantly different from the control.
Compared with the results of the MTT  assay, the viability values
measured by LDH leakage were less. The nature and difference of
sensitivity between these methods may  explain these differences.
The MTT  assay is based on enzymatic conversion of tetrazolium salt
into formazan by mitochondrial dehydrogenases [49], whereas the
LDH leakage assay is based on the release of the enzyme into the cul-
ture medium after cell membrane ruptures during apoptosis [50].
Fotakis and Timbrell [51] tested four different methods to evaluate
the viability of HepG2 cells against cadmium chloride: MTT, LDH,
neutral red and protein quantiﬁcation. All methods showed results
with different intensities, and the authors suggest that the MTT  is
more sensitive than the LDH assay. These data are in accordance
with the results obtained in the present work.
LDH release was also measured with primary hepatocytes, and
the results corroborate the results of the MTT  assay. The LDH release
results are shown in Fig. 3D, where a great increase of LDH release in
cells treated with Lr (∼58%) can be seen, while the incubation with
Ab did not produce a signiﬁcant effect. These data suggest that Ab
may  act selectively, being more aggressive to tumors (HepG2) than
to normal cells (hepatocytes), whereas Lr is toxic to both.
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Fig. 3. Cell viability assay by LDH release. Conditions for LDH release measurements are described in Section 2. LDH release of HepG2 cells treated with Lr and Ab after
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er  minute. The results represent the mean ± S.D. of four different experiments. Ast
.3. Cell morphology
Fig. 4A–C shows the morphology of HepG2 cells in the absence
Fig. 4A-control) or presence of Lr (Fig. 4B) and Ab (Fig. 4C) at a dose
f 200 g mL−1 incubated for 24 h. Fig. 4A (control) shows a high
ontact and conﬂuent culture of elongated HepG2 cells. Treatment
ith Lr (Fig. 4B) and Ab (Fig. 4C) fractions promoted a reduction
n cell adhesion and increased the number of cells with a round
orphology (indicated by the arrows), which is suggestive of cell
istress. These effects were more pronounced for Lr-treated cells
Fig. 4C) and are in agreement with the effects of polysaccharides
n HepG2 viability (Figs. 2A and 3A), in which Lr was the most
ytotoxic (200 g mL−1 and 24 h of incubation).
Assays with primary hepatocytes (Fig. 4D–F) are also in agree-
ent with the viability results (Figs. 2D and 3D). Fig. 4D shows
 highly conﬂuent culture with hepatocytes with a typical cubic
ell shape and often two nuclei. The treatment with Lr promoted
igniﬁcant alterations in cell morphology (Fig. 4E), with a predom-
nance of round cells and dark features, suggesting cell distress.
hese results coincide with the viability decrease (∼75%; Fig. 2D).
he treatment with Ab (Fig. 4F) did not promote signiﬁcant changes
n hepatocyte morphology, when compared with the control assay
Fig. 4D), and corroborates the viability results (Fig. 2D).
.4. ATP contentDuring the process of cell death, energetic and metabolic sta-
uses are modiﬁed according to the related pathway, particularly
ecrosis or apoptosis [52]. Apoptosis is an organized process that8 h (D). Note that 100% corresponds to 6.491 ± 0.101 mol L−1 of NADH consumed
 indicate signiﬁcant difference (***P ≤ 0.0001) relative to untreated control cells.
consumes energy, thus ATP levels are expected to decrease in com-
parison with necrotic cells. The ATP content of HepG2 cells treated
with -d-glucans is shown in Fig. 5. In this assay, the polysaccha-
rides were tested at a dose of 200 g mL−1 and incubated for 24 h
before harvesting. Acetylsalicylic acid (ASA) was used as positive
control because it is able to induce cell death of HepG2 by apoptosis
[53]. It was used at a concentration of 10 mmol L−1 and incubated
for 24 h. In this condition, ASA treatment promoted a reduction of
ATP content by ∼45% in comparison with the control (absence of
treatment). In turn, Lr and Ab treatment decreased the levels of ATP
by ∼14% and ∼27%, respectively, and the statistical data show that,
in comparison, this effect is different for the two polysaccharides
(data not shown). These results are consistent with the effects of Lr
on viability (Fig. 2A) and morphology (Fig. 4B); however, Ab is less
effective than Lr in modulating viability and morphology of HepG2
cells under the same experimental conditions (Figs. 2A and 4C,
respectively). Here, it is important to consider that the method-
ologies used are different and, therefore, do not have the same
sensitivity.
At ﬁrst glance, these results are unexpected because Lr was more
toxic to HepG2 cells than Ab.  However, Lr may  be able to induce cell
death, but not by apoptosis pathway. Thus, Ab may  be impairing the
ATP pathway, therefore decreasing the ATP content.
3.5. Cytochrome c releaseCytochrome c is released from mitochondria in response to cell
injury and triggers apoptosis [54]. High levels of cytochrome c in the
cytoplasm indicate that the cells are undergoing apoptosis. In our
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ere  incubated with Lr and Ab for 18 h. In sequence images were obtained using inv
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ssay, ASA was used as a positive control, promoting an increase
n cytochrome c release of ∼90% (Fig. 6). Treatment with Lr and
b also increased cytochrome c release at ∼66% and ∼20%, respec-
ively. Therefore, in this assay, Lr was also more effective than Ab
t increasing cytochrome c release, which corroborates the viabil-
ty and morphology results (Figs. 2A and 4B and C). These results
einforce the suggestion that Lr is able to induce HepG2 cell death
y apoptosis.. Discussion
The present research shows, for the ﬁrst time, the cytotoxic
ffects of -d-glucans from L. rufus and A. bisporus on human
ig. 5. Measurement of ATP content of HepG2 cell treated with Lr and Ab glucans.
onditions for ATP measurement are described in Section 2. HepG2 cells were incu-
ated with ASA (10 mmol L−1), Lr (200 g mL−1) or Ab (200 g mL−1) for 24 h before
TP measurement. Untreated HepG2 cells were used as a control, and 100% cor-
esponds to 1.612 ± 0.132 nmol of ATP per mg  protein. The results represent the
ean ± S.D. of three different experiments. Asterisks indicate signiﬁcant difference
*P  ≤ 0.05 and ***P ≤ 0.0001) relative to control cells. 2. HepG2 cells were incubated with Lr and Ab for 24 h, and primary hepatocytes
 microscopy. The images represent (A) untreated HepG2 cells; (B) Lr treated HepG2
ry hepatocyte; (F) Ab treated primary hepatocytes. Arrows indicate round cells.
liver hepatocellular carcinoma cells (HepG2). Both polymers were
cytotoxic, which may  occur by induction of cell death by apo-
ptosis, as shown by the ATP and cytochrome c assays. More
speciﬁc assays are necessary to conﬁrm these results; however,
other polysaccharides are known to decrease viability of tumor
cells by induction of apoptosis. An example is a protein-bound
polysaccharide (PSK) that is derived from the fungus C. versicolor
[55]. Treatment with 100 g mL−1 of PSK promoted decreased
cell viability of many cells line: B16F10, B9 murine MCA-induced
ﬁbrosarcoma, Ando-2 human melanoma, AGS human gastric can-
cer, A-549 human lung cancer, Hela and Jurkat T lymphoma
leukemia. An assay with annexin V/7ADD double staining and
caspases-3 expression showed that PSK promoted apoptosis. The
authors suggested that PSK has in vitro cytotoxic activity on tumor
Fig. 6. Measurement of cytochrome c release of HepG2 cell treated with Lr or Ab glu-
cans. Conditions for cytochrome c measurement are described in Section 2. HepG2
cells were incubated with ASA (10 mmol L−1), Lr (200 g mL−1) or Ab (200 g mL−1)
for  24 h before cytochrome c measure. Untreated HepG2 cells were used as a control,
and 100% corresponds to 0.1357 ± 0.0383 nmol of cytochrome c per mg  protein. The
results represent the mean ± S.D. of three different experiments. Asterisks indicate
a  signiﬁcant difference (***P ≤ 0.0001) relative to control cells.
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ell lines and that this effect is independent of PSK’s previously
escribed immunomodulatory activity. They also afﬁrmed that
he antitumor activity is due to cytotoxic and immunomodulatory
ffects. Similarly, an aqueous extract of Phellinus gilvus inhibited
roliferation of murine melanoma cells (B16F10) in vitro [56]. A
ose-dependent effect of this polysaccharide extract was signif-
cant in doses up to 50 g mL−1 and reached ∼80% inhibition at
50 g mL−1. Immunostained and TUNEL assays showed that a P.
ilvus extract decreased proliferation through apoptosis induction.
t was suggested that its anti-tumor action is due the induction
f tumor cell apoptosis and that P. gilvus is much less toxic when
ompared with chemical anti-tumor drugs.
The mechanism of anti-tumor action of polysaccharides has
ot yet been elucidated, but some investigations [55,56] have
hown that the anti-tumor effect of polysaccharides may  be
ue a combination of immunomodulatory and cytotoxic activi-
ies, although other pathways may  be involved. Recently it was
hown that a polysaccharide, MEP-II, isolated from the fermen-
ation broth of Morchella esculenta, was cytotoxic to HepG2 cells.
n that work, MEP-II was tested in a range of 150–1200 g mL−1
gainst HepG2, AS49 and HeLa cells and was found to be more
oxic to HepG2 cells. Annexin V-FITC/PI double stain, morphological
nalysis and mitochondrial potential results suggests that MEP-II
romotes apoptosis in HepG2. The measurement of reactive oxy-
en species (ROS) formation using a DCFH-DA probe showed an
ncrease in the accumulation of ROS in a concentration-dependent
anner. Pre-incubation with N-acetyl-l-cysteine, an antioxidant,
revented ROS formation and decreased the externalization of
hosphatidylserine. The authors suggest that ROS were most likely
he crucial upstream signaling molecule for MEP-II-induced apo-
tosis [4].
The mechanisms of Ab and Lr antitumor activity are not yet
nderstood, and the antitumor activity of other polysaccharides,
uch as those from mushrooms, can be due to a combination of
ffects. Another important aspect is the possible selective effect of
hese polymers. The results indicate that the most effective poly-
er  (Lr) was also cytotoxic for primary hepatocytes. However,
-d-glucan Ab showed a cytotoxic effect on HepG2 cells without
ffecting the viability of hepatocytes. This difference in the inten-
ity of cytotoxic action may  be related to their structure because Lr
as a branched structure, whereas Ab is a linear -d-glucan. These
ranches may  favor interaction with cell receptors and may  be nec-
ssary for the induction of cell death. This interaction may  be more
ffective in tumor cells than normal cells. Compounds that have
oxic effects on tumors and not on normal cells are very promising
nd promote an increased interest in the application of -d-glucans
n cancer therapy.
. Conclusion
The -d-glucans from L. rufus and A. bisporus were toxic against
uman liver hepatocellular carcinoma cells (HepG2), and this may
ccur by the induction of cell death by apoptosis. The L. rufus
-d-glucan was the most cytotoxic to HepG2 cells and was  also
ytotoxic to primary hepatocytes. However, A. bisporus -d-glucan
howed a cytotoxic effect on HepG2 cells without affecting hepato-
yte viability. These results may  open new biological applications
or mushroom -d-glucans.
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